THE DEAL, AT A GLANCE
From the announcementForlong
01What it doesForlong is a a Suzhou, China-based Digital Health company focused on advance its cytokine therapies.From the announcement
Summarized from the deal record's source announcement; not yet independently reviewed.
Read the announcement ↗02Who is involvedBacked by an undisclosed fund, Fudan Capital, Changshu Guofa Venture, Kunsheng Relay FundFrom the announcement
Summarized from the deal record's source announcement; not yet independently reviewed.
Read the announcement ↗03What happenedForlong raised $17.5M Pre-Seed, announced 2026-05-20From the announcement
Summarized from the deal record's source announcement; not yet independently reviewed.
Read the announcement ↗04Why it mattersForlong's $17.5M Pre-Seed positions the company as a smaller Healthcare & Life Sciences financing in a sector with broad recent capital flow, but below the median round…From the announcement
Summarized from the deal record's source announcement; not yet independently reviewed.
Read the announcement ↗Click a part to explore its evidence. Unsupported imagery is withheld rather than guessed.Original record source ↗
Forlong · Financing Record
Explore source-linked visual explanations for Forlong. Unsupported claims are withheld while source review continues.
Record 4112 · Recorded date: 2026-05-20
Explore company records →